Literature DB >> 16272192

Paroxetine (Paxil) and congenital malformations.

Megan Williams1, Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16272192      PMCID： PMC1283495          DOI： 10.1503/cmaj.051421

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

Review 1.  The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.

Authors:  Pär Hallberg; Viktoria Sjöblom
Journal:  J Clin Psychopharmacol       Date:  2005-02       Impact factor: 3.153

2.  Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

Authors:  Thomas R Einarson; Adrienne Einarson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-12       Impact factor: 2.890
  2 in total
  10 in total

1.  Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2006-05-02       Impact factor: 8.262

Review 2.  Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Authors:  N Byatt; K M Deligiannidis; M P Freeman
Journal:  Acta Psychiatr Scand       Date:  2012-12-14       Impact factor: 6.392

3.  Prevalence and patterns of antidepressant drug use during pregnancy.

Authors:  Tessa Ververs; Hans Kaasenbrood; Gerard Visser; Fred Schobben; Lolkje de Jong-van den Berg; Toine Egberts
Journal:  Eur J Clin Pharmacol       Date:  2006-08-08       Impact factor: 2.953

4.  Low-dose paroxetine exposure causes lifetime declines in male mouse body weight, reproduction and competitive ability as measured by the novel organismal performance assay.

Authors:  Shannon M Gaukler; James S Ruff; Tessa Galland; Kirstie A Kandaris; Tristan K Underwood; Nicole M Liu; Elizabeth L Young; Linda C Morrison; Garold S Yost; Wayne K Potts
Journal:  Neurotoxicol Teratol       Date:  2014-11-12       Impact factor: 3.763

Review 5.  The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.

Authors:  Anick Bérard; Noha Iessa; Sonia Chaabane; Flory T Muanda; Takoua Boukhris; Jin-Ping Zhao
Journal:  Br J Clin Pharmacol       Date:  2016-01-26       Impact factor: 4.335

6.  Case-based care for pre-existing or new-onset mood disorders in patients undergoing infertility therapy.

Authors:  Dikea Roussos-Ross; Alice S Rhoton-Vlasak; Katherine M Baker; Brittany J Arkerson; Georgia Graham
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

7.  A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.

Authors:  Courtney De Vries; Svetla Gadzhanova; Matthew J Sykes; Michael Ward; Elizabeth Roughead
Journal:  Drug Saf       Date:  2020-12-22       Impact factor: 5.606

8.  Quantification of cerivastatin toxicity supports organismal performance assays as an effective tool during pharmaceutical safety assessment.

Authors:  Shannon M Gaukler; James S Ruff; Tessa Galland; Tristan K Underwood; Kirstie A Kandaris; Nicole M Liu; Linda C Morrison; John M Veranth; Wayne K Potts
Journal:  Evol Appl       Date:  2016-04-15       Impact factor: 5.183

9.  Effect of Maternal Antidepressant Use During the Pre-pregnancy/Early Pregnancy Period on Congenital Heart Disease: A Prospective Cohort Study in Central China.

Authors:  Mengting Sun; Senmao Zhang; Yihuan Li; Letao Chen; Jingyi Diao; Jinqi Li; Jianhui Wei; Xinli Song; Yiping Liu; Jing Shu; Tingting Wang; Peng Huang; Jiabi Qin
Journal:  Front Cardiovasc Med       Date:  2022-07-05

Review 10.  Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation.

Authors:  Daya Ram; S Gandotra
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.